The recent FDA approval of teclistamab (Tecvayli) in combination with daratumumab (Darzelex) represents a significant shift in the treatment of relapsed/refractory multiple myeloma (R/R MM). According ...
The recent FDA approval of teclistamab (Tecvayli) and daratumumab and hyaluronidase-fihj (Darzelex Faspro) marks a major shift in the treatment paradigm, moving powerful bispecifi ...
How Does Blenrep Work for Multiple Myeloma? Blenrep is an antibody-drug conjugate (ADC), which is a type of targeted cancer medicine. ADCs contain two parts, a protein called an antibody and an ...
Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...
Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...
The blood cancer multiple myeloma, which involves infection-fighting plasma cells in the bone marrow, affects only about 1% of all cancers -- predominantly individuals over age 65. The disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results